The authors present the case of an elderly man with a primary dural-based intracranial synovial sarcoma. Histological and immunohistochemical profiles of the lesion were diagnostic for a synovial sarcoma, and molecular studies using fluorescenceinsituhybridizationwerecompatiblewithasynovialsarcoma.Awidearrayofspindlecellneoplasmshas been described as originating in the dura. To the authors' knowledge, however, this is only the second primary dura- 
D ura-baseD neoplasms are among the most common central nervous system tumors encountered by neurosurgeons. Although most are low-grade meningiomas, a multitude of tumors can arise from the dura mater and leptomeninges. Such tumors include rhab domyosarcomas, dendritic cell sarcomas, primitive neuroectodermal tumors/Ewing sarcomas, melanocytic tumors, hemangioblastomas, lipomas, leiomyomas, chon drosarcomas,hemangiopericytomas/solitaryfibrous tu mors, MPNSTs, and undifferentiated sarcomas, among others. 1, 2, 4, [6] [7] [8] 17, 20, 21, 26, 29, 36, 37 Moreover, even within the class of meningiomas there are 15 subtypes encompassing 3 grades of severity. 24 If metastatic and hematopoietic tumors are included as well, the possible differential diagnosis for meningeal tumors grows even larger. Thus, both neurosurgeons and neuropathologists must be wary when encountering such tumors because therapeutic regimens and prognoses frequently differ based on the tumor classification.Theauthorsrecentlyencounteredanexample of this difficulty in an elderly man with a left parietal lesion that ultimately proved to be a synovial sarcoma, most likely originating in the dura. The clinical, surgical, histological, and molecular aspects of this tumor are discussed.
Case Report
History and Presentation. This patient was an 81-yearold man with a medical history of diabetes, hypertension, hyperlipidemia, hypothyroidism, prostate cancer, tobacco abuse, peripheral vascular disease, and gastroesophageal refluxdisease.Forafewmonthshehadprogressivedifficultywithright-sidedweakness,ambulation,andspeech, and became increasingly agitated. Magnetic resonance imaging showed a 5 × 4-cm contrast-enhancing, durabased mass in the left parietal lobe with associated edema andadjacentsubarachnoidenhancement (Fig.1AandB ).
Operation and Postoperative Course. A left parietal craniotomy was performed using intraoperative ultrasonography guidance. The tumor was partially attached to the dura, with a gliotic plane between the tumor and the underlying brain parenchyma. Intraoperative pathological consultation was diagnostic of a high-grade neoplasm.Tumordebulkingwaslargelysuccessfulexceptat the most inferior and anterior part of the lesion, where a cortical vessel was encased by tumor. A postsurgical noncontrast CT scan did not detect the small portion of residualtumor (Fig.1C) .
The patient's postoperative course was complicated by mental status deterioration due to neurogenic hyper-ventilation-associated respiratory alkalosis. After the procedure, no other masses were detected on CT scans of the chest,abdomen,orpelvis(notshown).Thepatientrefused to undergo a bone scan. After a 10-day hospital stay the patient was stable enough to be discharged to a rehabilitation center. The patient was treated with multiple cycles of postoperative radiation therapy that ended 2 months after surgery. As of 5 months after the initial tumor resection, his right-sided numbness had subsided, his speech had improved, and he had switched from using a wheelchair to usingawalker.Follow-upMRimaginghasyettodemonstrate tumor regrowth or dissemination.
Immunohistochemical Analysis
Immunohistochemical studies of the tumor were performed on 4-μm-thick sections obtained from paraffinembedded material. The primary antibodies, including manufacturer, clone, and dilution, were as follows: CD56 (CellMarque,123.C3.D5,prediluted);CD99(Dako,12E7, 1:75); Bcl-2 (Cell Marque, 124, prediluted); p53 (Dako, DO-7, 1:100); vimentin (Ventana, V9, prediluted); SMA (CellMarque,1A4,prediluted);EMA(CellMarque,E29, prediluted); GFAP (Dako, polyclonal, 1:1000); S100 protein(Dako,polyclonal,1:500);CD34(Ventana,QBend10, prediluted);andcytokeratinAE1/3(Dako,AE1/3,1:100). The antibody labeling was performed using the avidinbiotincomplexmethodandvisualizedusingahorseradish peroxidaseen zymelabeland2′-diaminobenzamide(Dako) asthesubstratechromogen(brown)forallantibodies,with theexceptionofS100,whichwasvisualizedusinganalkalinephosphataseenzymelabelwithFastRed(Dako)asthe substrate chromogen.
Fluorescence In Situ Hybridization
Formalin-fixed paraffin-embedded sections were mounted and serially sectioned at 5-mm intervals. Sections stained with H & E were used by the pathologist to determine the area of the tissue to be targeted for analysis. TheFISHslidesweredeparaffinizedinxylenetwicefor 10 minutes, dehydrated twice with 100% ethanol, and then pretreatedusingtheVysisParaffinPretreatmentKit.Slides were digested for 18 minutes in protease solution (0.5 mg/ ml) at 37°C. Fluorescence in situ hybridization was performedusingtheSYTdual-colorbreak-apartprobe(Vysis, 
Inc.).Thetargetslideandprobewerecodenaturedat95°C
for 8 minutes and incubated overnight at 37°C in a humidified chamber. Posthybridization washes were performed using 2X standard saline citrate/0.3% Igepal (Sigma) at 72°C for 2 minutes. Slides were air-dried in the dark and counterstained with 4′,6′-diamidino-2-phenylindole(Vysis, Inc). Analysis was performed using a Nikon Optiphot-2 microscope(Nikon,Inc.)andQuipsGeneticWorkstation equippedwithaChromaTechnologyfilterfittedwithsingle-bandexcitorsforSpectrumOrange,fluoresceinisothiocyanate, and 4′,6′-diamidino-2-phenylindole (uv 360 nm; Vysis,Inc).Onlyindividualandwell-delineatedcellswere ThetumorwasnegativeforEMA(H),GFAP,S100,CD34,and cy to keratinAE1/3(GFAP,S100,CD34,andcytokeratinstainsnotshown).Originalmagnification× 100.
scored. Overlapping cells were excluded from the analysis.Approximately60cellswereanalyzedinthetargeted region.
The specimen was soft and tan-gray with focal hemorrhage. Microscopically the tumor was hypercellular and composed of plump spindle cells with numerous mitoses(about6per10hpf),manyofthematypical (Fig.2) . The cells were mostly arranged in large compact sheets, as well as in fascicles. No epithelioid areas were seen.
The tumor cells were strongly positive for CD56, CD99,Bcl-2,p53,andvimentin (Fig.3A-E) .TheproliferationmarkerMIB-1waspositivein>80%ofthecells (Fig.3F) .Smoothmuscleactinwasonlyweaklyandfocallypositive (Fig.3G),whereasEMA(Fig.3H) wasnegative. Glialfibrillaryacidicprotein,S100,CD34,andcytokeratin AE1/3werealsonegative(notshown).
The FISH analysis using a dual-color break-apart probe within the SYTgeneon18q11.2showedacomplex pattern in 100% of the cells, consisting of 1-3 fusion signalsalongwith1-3orangesignals (Fig.4) .
Reversetranscription-polymerasechainreactionon both the SYS-SSX1 and SYS-SSX2 fusion gene products was unsuccessful due to inadequate RNA quality from theformalin-fixed,paraffin-embeddedtissue.
Discussion
Synovialsarcomaisawell-characterizedhigh-grade mesenchymal neoplasm most commonly arising in the extremitiesofyoungeradults. 39 It was originally believed to arise from the synovial tissues of joints, but now it is be lievedtoarisefrom(currently)undefinedmultipotent stemcells,whichwouldexplainwhyasynovialsarcoma is so often biphasic with epithelioid and mesenchymal com ponents. As in this case, however, the majority of synovial sarcomas are monophasic spindle-cell neoplasms that can easily be confused with MPNSTs, high-grade hemangiopericytomas, leiomyosarcomas, or fibrosarcomas. 1, 21, 25, 29, 32, 33, 36, 37 The differential diagnosis for duraas sociated tumors also includes anaplastic meningiomas (Ta ble1).
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Immunohistochemical and Molecular Characteristics
Fortunately,theimmunohistochemicalprofileofsynovialsarcomasisfairlydistinct,withcoexpressionofvimentin,CD99,Bcl-2,andCD56essentiallyrulingoutall other tumors. 15, 28, 39 A positive stain for cytokeratin and/or EMA is often observed, especially in the epithelioid component, but is not mandatory for diagnosis when encountering the monophasic spindle-cell variant. 28, 39 WeakSMA is often seen, as in this case, but should not be confused with a leiomyosarcoma, which is usually more strongly reactive. 39 Synovial sarcomas are one of the relatively few neoplasms known to have a characteristic molecular signature. In this case, the SYT gene on 18q and either the SSX1 or SSX2 gene on Xp undergo a re ciprocal translocation, forming a fusion SYT-SSX gene and subsequent fusion protein. The specific actions of this protein have not yet beenfullyelucidated,butitdoeslocalizetothenucleus, has both transcriptional promoter and depressor capabilities, and appears to act on DCC, a tumor suppressor gene originally described in colorectal carcinomas. 10, 22, 23, 34 Additionally, the fusion protein has been shown to promote tumorigenesis and proliferation by upregulating cyclins A and D1, downregulating the proliferation inhibitor COM1, and initiating β-catenin/Wnt signaling. 18, 30, 42, 43 More than 90%ofsynovialsarcomashavethishighlyspecifict(X;18) signature. The SSX2 variant of the fusion gene appears to be more common in monophasic than in biphasic synovial sarcoma, but whether the SSX1 or SSX2 translocation produces a more aggressive tumor is controversial. 10, 14, 22, 34 Regardless, aggressive behavior does appear to correlate well withahighMIB-1proliferationindexandnuclearp53ac-cumulation, 3 both of which were observed in this case. The molecular analysis of synovial sarcoma can be performed using classic karyotyping or polymerase chain reaction, but the technique most often used in routine clinicaldiagnosticsisFISHbecauseitcanbeperformed on formalin-fixed, paraffin-embedded tissues, requires few cells, and is technically simple. 23 The most widely usedsetofFISHprobeslabelsa1044kbDNAsequence proximaltotheSYTgenewithagreenfluorophore,while asecondprobewithanorangefluorophorebindstoa650 kb segment of DNA that includes the distal end of the SYT gene. Thus, the normal unbroken 18q11.2 region will have a close apposition of the green and orange fluorophores,producingasingleopticallyyellowsignal.When the 18q11.2 region is broken at the critical junction betweentheprobes,asintheclassict(X;18)signature,the signal will split into separate green and orange signals.
The"breakapart"approachtoFISHinsynovialsarcoma has the advantage of detecting any translocation involving the SYT gene, but does not identify the translocation partner. In most cases it does not matter, because the classic positive result is 1 yellow fusion signal, 1 green signal, and 1 orange signal. Our case, however, produced acomplexpatternwherein1-3yellowfusionsignalswere observed per tumor cell, along with 1-3 orange signals without a green counterpart (Fig. 4) . This finding sug- gests that there was variable aneuploidy of chromosome 18, or at least of 18q, along with an interstitial deletion of at least the 1044 kb sequence labeled by the green probe in 18q11.2. That all tumor cells carried at least 1 independent orange signal suggests disruption or translocation in the SYT gene region. Synovial sarcomas with chromosomalaberrationsinadditiontot(X;18)havebeen well documented and sometimes involve monosomy or trisomy of the chromosome 18 copy that is uninvolved in the translocation. 34 Such extensive chromosomal abnormalities are often noted in more aggressive synovial sarcomas, as this case would appear to be, judging by the mitoticindex,MIB-1proliferationindex,andnuclearp53 accumulation (Figs.2and3) .
Clinical and Biological Characteristics
Although synovial sarcomas are far more common in the distal extremities of younger adults, primary tumors have been described in such unusual locations as the lung, head and neck, mediastinum, abdominal wall, and paraspinal region. 5, 16, 19, 35, 38, 40 Only 2 primary intradural synovial sarcomas have been reported within the spine, and only 1 in the brain. 12, 21, 33 Although the dura most commonly produces meningiomas, it is quite capable of giving rise to other spindle cell neoplasms like hemangiopericytomas, solitaryfibroustumors,dendriticcellsarcomas,rhabdomyosarcomas, primitive neuroectodermal tumors/Ewing sarcomas, MPNSTs, and undifferentiated sarcomas, among others. 1, 2, 4, 6, 8, 17, 20, 21, 26, 29, 36, 37 Even though primary dura-based synovialsarcomasarerare,theydoexist.
To date, our patient has refused a bone scan, which would of course be essential to unequivocally rule out a primary tumor site in the extremities. However, if this large dural mass were only a metastatic lesion, the primarysitewouldalmostcertainlybeofsuchasizeasto have already manifested itself clinically. Such was the case in an elderly woman who presented with a hemorrhagic cerebellar synovial sarcoma that was found to have metastasized from a 20-cm right popliteal mass originallymisdiagnosedasalargeBakercyst. 31 Furthermore, asynovialsarcomaoftheextremitiesthatmetastasizedto thebrainwouldbeexpectedtohavemetastasizedtoother sites in the body, and CT scans of the chest, abdomen, and pelvis in this patient were negative. Thus, it is reasonable to conclude that this mass most likely is the primary site in this patient.
Surgical Management, Adjuvant Therapy, and Prognosis
Much has been learned about the genetic makeup of synovial sarcomas, but it has yet to translate into targeted therapy.Whenthetumorarisesinatypicalsiteintheextremities, the most critical part of treatment continues to be complete excision with negative margins and sparing of the limb when possible. If the lesion is small and superficial,andisnotassociatedwithboneorneurovascular structures, no adjuvant treatment is indicated. If, however, the tumor is in the deep soft tissue and/or is close to bone or neurovascular structures, adjuvant radiation ther apy is usually administered. 9, 11 This combined modality has proven highly effective at reducing the local recurrence risk to < 10% for many soft-tissue sarcomas. 41 Unfortunately, a synovial sarcoma is a high-grade tumor; even with combined surgery and radiation almost half of all patients will either have a local recurrence or distant metastases within 10 years, with risk of the latter increasing sharply when the tumor size exceeds 5 cm. Chemotherapy (commonly doxorubicin-based)isusuallyonlyadministeredatthediscretion of the oncologist, and only if the primary tumor is >5cm.Whetherchemotherapyreducestheriskofmetastases or enhances survival is controversial. 13 Synovialsarcomasoftheextremitiesarerareenough, but synovial sarcomas of the dura are even rarer. Thus, no studies exist that systematically evaluate optimal treatment. The most reasonable approach is therefore similar to the treatment of anaplastic meningioma; namely, striving for total resection and following up with radiotherapy orstereotacticradiosurgerybutnotchemotherapy.Fractionatedradiotherapyatadoseof50-60Gyisthemost widely accepted treatment for anaplastic meningioma 27 and is similar to treatment for synovial sarcomas of the extremities.
13
Regarding the prognosis of synovial sarcoma, the 5-year survival rate is ~ 65%.
14 This rate includes those patientswithtumorsintheextremities,whichtendtohavea better prognosis. As mentioned above, other variables contributingtothesurvivalrateincludethesizeofthetu mor and the presence of metastases. An intracranial, dura-based synovial sarcoma with particularly aggressive features such as ours would appear to have a poor prognosis, and the rare intraspinal or intracranial cases described so far in the literature have all met with a dismal outcome. 12, 21, 33 Although the leptomeningeal en hancement in this patient was initially worrisome for tumor spread beyond the main mass, as of 5 months postsurgery no spread has been proven radiologically. Nevertheless, the encasing of the cortical bloodvesselbythetumorandthedifficultyincompletely excising the lesion correlate well with the histological high-gradefeatures.Serialfollow-upimagingisexpected to eventually show recurrence and spread.
Conclusions
Wereportacaseofprimaryintraduralsynovialsarcoma in the cranium. To our knowledge, this is only the second such case described in the literature. Although the molecularsignatureofthetumorwascomplex,thehistologicalappearanceandimmunohistochemicalprofilewere diagnostic and ruled out all other spindle cell tu mors. Thus, a wide differential diagnosis is necessary when confronted with such neoplasms in the dura.
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